DNAAF4

dynein axonemal assembly factor 4, the group of Tetratricopeptide repeat domain containing|Axonemal dynein assembly factors

Basic information

Region (hg38): 15:55410525-55508234

Previous symbols: [ "DYX1C1" ]

Links

ENSG00000256061NCBI:161582OMIM:608706HGNC:21493Uniprot:Q8WXU2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • primary ciliary dyskinesia 25 (Strong), mode of inheritance: AR
  • primary ciliary dyskinesia (Supportive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Ciliary dyskinesia, primary 25ARAllergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; PulmonaryPulmonary and audiologic surveillance may be beneficial to assess respiratory and hearing function and institute early management measures; In order to facilitate mucus clearance, aggressive interventions (eg, chest percussion and oscillatory vest), as well as vaccinations and early and aggressive treatment of respiratory infections may be beneficial, though measures including lobectomy or lung transplantation may be necessary; Individuals may require surgery or other interventions related to congenital cardiac malformationsAllergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Gastrointestinal; Pulmonary23872636

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DNAAF4 gene.

  • not provided (16 variants)
  • Primary ciliary dyskinesia 25 (6 variants)
  • Primary ciliary dyskinesia (3 variants)
  • Dyslexia, susceptibility to, 1 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNAAF4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
34
clinvar
1
clinvar
36
missense
1
clinvar
92
clinvar
5
clinvar
5
clinvar
103
nonsense
5
clinvar
3
clinvar
1
clinvar
1
clinvar
10
start loss
1
clinvar
1
frameshift
11
clinvar
4
clinvar
15
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
2
clinvar
4
clinvar
6
splice region
4
8
12
non coding
2
clinvar
31
clinvar
41
clinvar
74
Total 18 13 97 70 48

Highest pathogenic variant AF is 0.0000858

Variants in DNAAF4

This is a list of pathogenic ClinVar variants found in the DNAAF4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-55418091-G-A Uncertain significance (Aug 01, 2023)2645366
15-55429621-TCCTGGCTAACATGGTGAAACCCCATCTCTACTAAAAATGCAAAAAATTAGTCAGGCGTGGTGGCAGGCGCCTGTAGTCCCATCTACTCGGGAGGCTAAGGCAGGAGAATGGCCTGAACCCAGGAGGCAGAGCTTGCAGTGAGCCAAGATCGCGCCATTGCACTCCAGCCTGGGCAACAAAGGGAGACTTCCTCCGTCTCAAAAAAAAAAAAAAACCTTTAAAATTTAATTAGAGAATTACAGTAACTACAAGCAAAAGGGAAGCTGTGCTATTGTGCTTAACACTTGCATAATCCCAGTGATACAACACAAATGATGGTGCAGTCCAATACCAATACCATAATATTCCAGGTTAATATCTTACACTTTGCTGTCTTTTCTCCCCCTTGTCTACTTGGAGGTACTAGAAAACTATTTCACTCAAAAATTTATCTTCACCAGATAGTGTTATGAAATATGATCAGTTTTCAGGTGCACAGCCTATAAATGAAGTTGAATATAAGGTTTTCTAAACAGTTGTTTTATACTAGGCTGAACTGGTCTAATCTTGAACAACAAGCATTAGAGAAGTATTAAACAAAAAAATAAGGTTCTGTGCAGTTGGAAACTAACGGACAACCTGTCAATATTTATTATACCAAAGTCAACCATTCAGTCAATTAAATGGTATATTAATACAAACAAAAGTTATTTATAAATCTTTTATTTTAAAATTCTACCTTGTTAAAAATTAATCAGTAAGTGTCCTGGTAACTATACCAAAACATATTTTGTTACAAGGGCAAGCTTAATTCAGTAACACAAAAAAGTATACATATGTATTAATATGAAGAAATAAGGAATTAAAATAGATTCTTATTTAGATTTACTTATTCAGAAATGATTCAAGTCAAACAGTTTATTTTCTATAGATTTATAATATTTTGCCCTCAACAGAACTAAAGTACTAAACAGAAAGCGATTCTGTACAACTGGCCATAATATGTACAAAGATGCCTCCAGTTGTTTTTAAAAAACTTATAACAATACTTAGTTACTTCTAATAGTCATTAAGATTTTAGTTCTGTTCCTTGAATTACATTCCGAATCTTCTCAGCATCAATTTGTACAATTTTGTTGGATGGATCAATCTTAAGTGCCGCTTCATAATCCTGTAGGCCTGTGTTTATATAGCAATGATGATTAATACAATAAATATTTTATTAGCACTTCTTTTATCTAGACAATAGTTGTTTAAAATAAAAATAATCACTAGTAGCATGGTTCAGAACAAGTACCAAGTTTTAAATTAGATTCCCATCTTTTTTTTTTGAGACAGAGTCTCCTTCTGTTGCCCAGGCGGGAGTGCAGTGGCATGATCTCGGCTCACTGCAAGCTCTGCCTCCTGGGTTCACACCATTCTTCTGCCTCAGCCTCCTGAGTAGCTGGGACTACAGGCACCTGCCACCACACCTGGCTAATTTTTTGTATTTTTAGTAGAGATGGGGTTTCACCGTGTTAGCCAGTAGGGCCTCGATCTCCTGACCTCATGATCCACCCACCTTGGCCTCCCAAAGTGCTGGGATTACAGGTGTGAGCCACCGTGCCCGGCCCCTAAATCTATCTAAAATAAAATAAAATAAATGCTATATTTTCTGTATACATAGAGCTAAATTACAGAACTTAATACAATCTAACAAATATAAGCAATGTGCATGCACTATGGTGGATCAGTTATTTCCGAGCTTAGGTGTGTGTATACACACACACACACACACACACACACACACAAATACATACATACATACAGGGATGACCGAAGAAGCTCTCTGAGATAAATATCCATGATATCTCAAATCATTTATATATTTTATCTTTTTTTTTTTTTTTTTGGAGACAGAGTCTTGCTCTGTCACCCAGGCTGTAGCGCAGTGGCGTGATCTTGGCTCACTGCAAGCTCTGCCTTCCGGGTTCACGCCATTCTCTGGCCTCAGTCTCCTGAGTAGCTGGGACTACAGGCGCCCGCCACCACACCTGGCTAATTTTGTTTTTGTATTTTTAGTAGAGACGGGGTTTCACCGTGTTAGCCCGGATGGTCTTGATCTCCTGACCTTGTGATCCACCTGCTTCGGCCTCCCAAAGTGCTGAGATTACAGGCATAAGCCACCACACCCAGCCTATCATGTATTTTTTTTTTTTAAGAGACAGGGTCTCACTATGTTGCCCAAGCTGGTCTCAAACTCCTGGCCTCAAGCCATCCTTCCACCTCAGCCTCCCCAGTTCCTGGGATTATAGGCGTGAAGCACCACACCCAGCATTTATCACACGTTTCTATGAAGAGTTGTCTGGTAATATAGCATTTTTTTTTTTTTTGAGAAGGAGTTTCGCTGTTGTTGCCCAGGCTGGAGTGCAATGACATGATCTCGGCTCACCACAATCTCCGCCTCCCGGGTTCAAGGGATTCTCCTGCCTTAGCCTCCCAAGTAGCTGGGATTACAGGCATGTGCCACTACGCCAAGCTAATTTTGTGTTTTTAGTAGAGGGTTTCTCCATGTTGGTCAGGCTGGTCTCGAACTCCCGACCTCAGGTGATCCACCCGCCTCTGCCTCCCAAAGTGCTGGGATTACAGGCATGAGCATCTGCACCCAGCTAATATAGCATTTTTCTAGACTGAAACTTGTTGTTTACACTTATTTTAATTCTCTTCTACAATGAATTTTTTAAATATAATTTAGAAATCATGTATTGTCAGATATACTGCAGACATTACTAAGAATAAATTAAATGCTAAAAATATTTAAAAATGGAGTCCTTAAAAGTCACGATCTTAAATAATTCCAATGACATTTTTTTCAGAGTATAACTTGGGACTTAAACCATTTCTATCAATTCCTTACCTTCTACATACAATTCTAGTTGACAGAATGCTGTTCCACGTCGTACATGTGCCTTCATTCTTGCATTAGCATTGTCTGTAACAGGTGGCATCAATAATTCCAGTGCCTTACAAAATATATATAATTATTACAAGAAAGTTATAGTTTCTTAATTTAAACAAGCAAAAGGCTGGGCATGGTGGCTCACGCCTGTAATCCCAACACTTGGGGAGGCCGAGGTAGGTGGATCACCTGAAGTCAGGATTTTGAGACCAG-T Primary ciliary dyskinesia Pathogenic (Apr 01, 2020)916127
15-55430674-G-C not specified Benign (Jan 31, 2024)262314
15-55430684-C-A Dyslexia, susceptibility to, 1 • not specified • Primary ciliary dyskinesia 25 Benign (Jan 31, 2024)2136
15-55430685-T-C Likely benign (Dec 30, 2019)1082173
15-55430692-T-G Primary ciliary dyskinesia 25 • Inborn genetic diseases • Dyslexia, susceptibility to, 1 Uncertain significance (Sep 22, 2024)410958
15-55430704-C-A Uncertain significance (Jul 22, 2023)1044412
15-55430706-A-T Likely benign (Jun 28, 2022)1912622
15-55430708-T-A Uncertain significance (Sep 22, 2016)410962
15-55430712-C-G DNAAF4-related disorder Uncertain significance (Sep 19, 2022)2637240
15-55430717-C-G Uncertain significance (Aug 22, 2022)454959
15-55430720-C-G Inborn genetic diseases Uncertain significance (Jan 26, 2022)3083346
15-55430728-A-G Inborn genetic diseases Uncertain significance (May 29, 2024)3272526
15-55430729-C-T Uncertain significance (Oct 18, 2023)2724744
15-55430733-T-A Uncertain significance (Mar 17, 2020)1018752
15-55430734-T-C Uncertain significance (Aug 24, 2021)1395039
15-55430737-T-C Uncertain significance (Aug 04, 2023)858060
15-55430742-T-C Likely benign (Nov 15, 2023)1540572
15-55430743-G-A Uncertain significance (Sep 13, 2022)2068851
15-55430749-A-C Inborn genetic diseases Uncertain significance (Sep 29, 2022)3083344
15-55430756-G-A Uncertain significance (Jul 17, 2023)960625
15-55430757-T-C Inborn genetic diseases Likely benign (Dec 26, 2023)2886209
15-55430760-C-T Likely benign (Jul 17, 2018)762730
15-55430761-G-A Inborn genetic diseases Uncertain significance (Oct 07, 2023)2167706
15-55430768-A-G Uncertain significance (Jan 10, 2022)1695681

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DNAAF4protein_codingprotein_codingENST00000321149 997710
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
9.72e-100.5031257020461257480.000183
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.8672512151.170.00001112763
Missense in Polyphen10378.4431.3131925
Synonymous-1.358974.21.200.00000372736
Loss of Function1.141722.90.7440.00000123296

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003070.000301
Ashkenazi Jewish0.0001070.0000992
East Asian0.0001090.000109
Finnish0.0003700.000370
European (Non-Finnish)0.0002040.000202
Middle Eastern0.0001090.000109
South Asian0.0001330.000131
Other0.0001710.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Axonemal dynein assembly factor required for ciliary motility. Involved in neuronal migration during development of the cerebral neocortex. May regulate the stability and proteasomal degradation of the estrogen receptors that play an important role in neuronal differentiation, survival and plasticity. {ECO:0000269|PubMed:19423554, ECO:0000269|PubMed:23872636}.;
Disease
DISEASE: Ciliary dyskinesia, primary, 25 (CILD25) [MIM:615482]: A disorder characterized by abnormalities of motile cilia. Respiratory infections leading to chronic inflammation and bronchiectasis are recurrent, due to defects in the respiratory cilia. Patients may exhibit randomization of left-right body asymmetry and situs inversus, due to dysfunction of monocilia at the embryonic node. Primary ciliary dyskinesia associated with situs inversus is referred to as Kartagener syndrome. {ECO:0000269|PubMed:23872636, ECO:0000269|PubMed:25186273}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.0841

Intolerance Scores

loftool
rvis_EVS
1.09
rvis_percentile_EVS
91.85

Haploinsufficiency Scores

pHI
0.0983
hipred
N
hipred_score
0.170
ghis
0.424

Essentials

essential_gene_CRISPR
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Mouse Genome Informatics

Gene name
Dyx1c1
Phenotype
respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; craniofacial phenotype; cellular phenotype;

Zebrafish Information Network

Gene name
dnaaf4
Affected structure
pronephric glomerulus
Phenotype tag
abnormal
Phenotype quality
decreased thickness

Gene ontology

Biological process
neuron migration;cilium movement;epithelial cilium movement;determination of left/right symmetry;heart development;regulation of intracellular estrogen receptor signaling pathway;outer dynein arm assembly;inner dynein arm assembly;regulation of proteasomal protein catabolic process
Cellular component
nucleus;cytoplasm;centrosome;cytosol;plasma membrane;non-motile cilium
Molecular function
protein binding;estrogen receptor binding